Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Highlights • We assessed real-world survival outcomes for 1 L I-O in patients with advanced NSCLC. • Survival estimates were generally lower than those reported in pivotal trials. • There is room for improvement of outcomes in patients who receive 1 L I-O regimens. • Specific subgroups may have limited treatment benefit from current I-O therapies.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
